Off-label Medication Use In Oncology Cancer Research and Medicinal Drugs Cancer research and innovation are highly active, resulting in the introduction of new medications into the therapeutic arsenal. However, incorporating these new drugs into clinical practice is a challenging and time-consuming process due to regulatory requirements. Before a drug can be marketed and
Monocytosis And Patient Risk Of Malignancy And Mortality
Monocytosis And Patient Risk Of Malignancy And Mortality Monocytosis is a common occurrence in primary care, but its significance is not always clear. In adults, monocytosis is defined as having a higher-than-normal count of monocytes (a type of white blood cell) in the peripheral blood, specifically above 0.8 x 10^9/L. Monocytosis
Bedside Pediatric Early Warning System: A Validation Study
Bedside Pediatric Early Warning System: A Validation Study Overview Conducted in an 80-bed pediatric oncology specialty hospital in the Netherlands, this research was initiated to evaluate the predictive utility of the adapted Bedside Pediatric Early Warning System (BedsidePEWS) score. This study aimed to explore the correlation of this score with unanticipated transfers
Chronic Hyponatremia in Acute Heart Failure
Chronic Hyponatremia in Acute Heart Failure Overview This study aimed to comprehensively assess hyponatremia in patients with acute heart failure (AHF), focusing on its prevalence, associations, hospital course, and post-discharge outcomes. The research analyzed a cohort of 8,298 AHF patients from the European Society of Cardiology Heart Failure Long-Term Registry, regardless of
Massage Therapy For Oncology Patient Pain
Massage Therapy For Oncology Patient Pain Overview This study aimed to investigate the impact of massage therapy (MT) as a nonpharmacologic approach for addressing various symptoms experienced by children, adolescents, and young adults with hematologic and/or oncologic conditions. The researchers focused on two patient groups: those with sickle cell disease (SCD) and
Eyelid Rhabdomyosarcoma Survival In Children’s Oncology
Eyelid Rhabdomyosarcoma Survival In Children's Oncology Overview Survival outcomes in Orbital Rhabdomyosarcoma (ORMS) typically show excellent results, especially in low-risk cases (stage 1, group I-III, embryonal RMS). However, long-term follow-up data on low-risk ORMS and less common subgroups treated in recent Children's Oncology Group (COG) trials were previously unreported. To fill this
Injured Athletes: A Meta-Analysis Comparing Topical And Oral Analgesic Efficacy
Injured Athletes: A Meta-Analysis Comparing Topical And Oral Analgesic Efficacy Overview Injured athletes often resort to analgesic medication for pain relief, employing both non-prescription topical and oral medications without comprehensive guidance. However, the efficacy of such pain medications in injured athletes, as compared to a placebo, has not been extensively studied. To
Acute Myeloid Leukemia And Diverse Patient Survival Outcomes
Acute Myeloid Leukemia And Diverse Patient Survival Outcomes Background Cancer remains a prominent global health concern, accounting for a significant number of cases and fatalities worldwide in 2020, with projections indicating further increases in both incidence and mortality rates, particularly in the United States. Hematologic malignancies (HMs) constitute a substantial subset of
ABA Billing: A Complete Guide for Medical Facilities
ABA Billing: A Complete Guide for Medical Facilities Recently, ABA therapy has emerged as a leading treatment for individuals with autism spectrum disorder. For medical professionals and facilities that provide this essential treatment, understanding the intricacies of the billing process is vital to ensure on-time reimbursement, sustainable operations, and optimal care.
Sarcopenia And Chronic Kidney Disease
Sarcopenia And Chronic Kidney Disease Overview Sarcopenia and frailty are common conditions among people with chronic kidney disease (CKD), which may further enhance their risk of developing adverse health complications. Only a few studies have demonstrated the association between sarcopenia, frailty and chronic kidney disease in patients who are not on dialysis.
